Skip to main content
Premium Trial:

Request an Annual Quote

Iconix Inks Chemogenomics Deal with Lilly

NEW YORK, Nov. 24 (GenomeWeb News) - Iconix Pharmaceuticals said thoday that it has signed a deal to provide chemogenomics profiling and analytical services to drugs giant Eli Lilly.


According to Iconix, its chemogenomic technology is used to evaluate the genomic effect of a chemical compound on an intact biological system.


Terms of the arrangment were not disclosed.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.